Last A$0.10 AUD
Change Today 0.00 / 0.00%
Volume 0.0
As of 9:05 PM 01/21/15 All times are local (Market data is delayed by at least 15 minutes).

medical australia ltd (MLA) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/31/14 - A$0.39
52 Week Low
11/10/14 - A$0.06
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDICAL AUSTRALIA LTD (MLA)

Related News

No related news articles were found.

medical australia ltd (MLA) Related Businessweek News

No Related Businessweek News Found

medical australia ltd (MLA) Details

Medical Australia Limited develops, manufactures, and distributes medical devices and animal health products for the healthcare industry in Australia, Asia, the United States, and the United Kingdom. The company’s products primarily include IV systems, safety, blood banking, surgical, anaesthesia, and animal stem cell products. It also provides sterile and non-sterile medical plastics for use in surgery and transfusion; and manufactures and supplies products for veterinary surgeons. In addition, the company offers various wall mounted suction devices enabling the aspiration of fluids from patients in clinical applications; oxygen therapy devices for the measurement and distribution of oxygen; and mobile, portable, and manual suction pumps for surgical, emergency, and ward applications. Further, it provides specialty centrifuges for the laboratory, education, and field work for various industries and applications. The company was formerly known as BMDI Tuta Limited and changed its name to Medical Australia Limited in October 2009. Medical Australia Limited was founded in 2001 and is headquartered in Lidcombe, Australia.

23 Employees
Last Reported Date: 09/30/14
Founded in 2001

medical australia ltd (MLA) Top Compensated Officers

Chief Executive Officer and Chief Operating O...
Total Annual Compensation: A$78.1K
General Manager of Corporate Innovation
Total Annual Compensation: A$181.9K
Compensation as of Fiscal Year 2014.

medical australia ltd (MLA) Key Developments

Medical Australia Limited Appoints Darryl Ellis as Chief Executive Officer

Medical Australia Limited announced that it has appointed Darryl Ellis to the position of Chief Executive Officer of the company, effective immediately. Mr. Ellis joined MLA in February 2014 in the capacity of Chief Operating Officer, and since this time has been instrumental in the integration of the MediVet subsidiary into the Company, significantly lowering the cost base of the combined businesses. He has also driven a program of restructure and rationalization which has enabled MLA to return to profitability.

Medical Australia Limited, Annual General Meeting, Nov 06, 2014

Medical Australia Limited, Annual General Meeting, Nov 06, 2014., at 11:30 AUS Eastern Standard Time. Location: Gould Ralph, Level 29, Suncorp Place. Agenda: To consider adoption of remuneration report; to consider re-election of Geoffrey Cumming as a Director; to consider election of Bruce Hancox as a Director; and to consider election of Jeremy Delk as a Director.

Medical Australia Limited Announces Audited Consolidated Earnings Results for the Year Ended June 30, 2014

Medical Australia Limited announced audited consolidated earnings results for the year ended June 30, 2014. For the period, the company reported sale of goods was $11,874,962 against $9,152,303 a year ago. Profit before interest and income tax was $119,381 against loss of $1,219,293 a year ago. Profit before income tax was $24,945 against loss of $1,377,053 a year ago. Profit for the year after income tax was $73,613 against loss of $1,316,146 a year ago. Net profit attributable to owners of the parent entity was $105,241 against loss of $1,316,146 a year ago. Diluted earnings per share were 0.14 cents against loss of 2.90 cents a year ago. Net cash used in operating activities was $1,021,092 against $745,090 a year ago. Payments for property, plant and equipment was $62,187 against $67,674 a year ago. EBITDA solid at $328,539. Revenue increased 30% reflecting the contribution from the MediVet business that was acquired during the year but also from organic sales growth achieved in the human healthcare division.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MLA:AU A$0.10 AUD 0.00

MLA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MLA.
View Industry Companies

Industry Analysis


Industry Average

Valuation MLA Industry Range
Price/Earnings 58.4x
Price/Sales 0.7x
Price/Book 0.8x
Price/Cash Flow 35.0x
TEV/Sales 0.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICAL AUSTRALIA LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at